TriSalus Life Sciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	346	153	222	313	309	-
Market Cap Growth	186.02%	-31.30%	-29.05%	1.52%	-	-
Enterprise Value	343	165	203	-	-	-
Last Close Price	6.64	5.01	8.45	10.03	9.88	-
PS Ratio	5.46	5.19	12.01	25.28	36.75	-
PB Ratio	-	-5.90	-8.22	-25.43	9.99	-
EV/Sales Ratio	8.54	5.60	10.95	-	-	-
Debt / Equity Ratio	-1.28	-0.91	-0.06	-0.16	-	-0.84
Asset Turnover	1.26	1.21	0.80	0.41	0.37	-
Inventory Turnover	1.77	1.25	1.30	1.63	1.28	-
Quick Ratio	2.54	1.33	1.04	0.34	4.97	0.09
Current Ratio	3.06	2.02	1.42	0.53	5.51	0.11
Return on Equity (ROE)	-	-	-	-507.96%	-	-
Return on Assets (ROA)	-61.10%	-93.08%	-134.61%	-76.13%	-65.35%	-
Return on Capital (ROIC)	-375.12%	-	-	-221.74%	-131.01%	-
Return on Capital Employed (ROCE)	-122.30%	-263.20%	-506.30%	351.70%	-76.40%	55.00%
Earnings Yield	-21.35%	-19.67%	-26.70%	-15.05%	-9.34%	-
FCF Yield	-6.68%	-26.96%	-23.01%	-10.52%	-7.71%	-
Buyback Yield / Dilution	-36.08%	-169.61%	-2934.71%	96.51%	-15.52%	-

Updated Nov 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q